207 related articles for article (PubMed ID: 10748552)
1. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
2. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
3. Syncytium forming capacity of HIV 1 strains in inhibited by pretreatment of CD4 expressing cells with 3'-azido-3'-deoxythymidine but not by alpha interferon.
Ruţă SM; Cernescu C
Rev Roum Virol; 1994; 45(3-4):171-83. PubMed ID: 7619738
[TBL] [Abstract][Full Text] [Related]
4. HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture.
Sylwester A; Murphy S; Shutt D; Soll DR
J Immunol; 1997 Apr; 158(8):3996-4007. PubMed ID: 9103471
[TBL] [Abstract][Full Text] [Related]
5. The influence of cell culture and storage conditions on HIV-1 infectivity and fusogenic activity.
Ongrádi J; Ceccherini-Nelli L; Szilágyi JF; Specter S; Pistello M; Laird HM; Bendinelli M
Acta Microbiol Hung; 1992; 39(3-4):207-21. PubMed ID: 1285337
[TBL] [Abstract][Full Text] [Related]
6. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Naeger LK; Margot NA; Miller MD
Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
[TBL] [Abstract][Full Text] [Related]
7. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
[TBL] [Abstract][Full Text] [Related]
8. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
Chowdhury MI; Koyanagi Y; Suzuki M; Kobayashi S; Yamaguchi K; Yamamoto N
Virus Genes; 1992 Jan; 6(1):63-78. PubMed ID: 1347963
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
[TBL] [Abstract][Full Text] [Related]
11. [Anti-HIV-1 effect of compound K3 from flower of Japanese pagoda tree in vitro].
Zhang GH; Zheng YT
Zhong Yao Cai; 2006 Apr; 29(4):355-8. PubMed ID: 16913492
[TBL] [Abstract][Full Text] [Related]
12. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
Jeeninga RE; Keulen W; Boucher C; Sanders RW; Berkhout B
Virology; 2001 May; 283(2):294-305. PubMed ID: 11336554
[TBL] [Abstract][Full Text] [Related]
13. Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication.
Bahbouhi B; Bendjennat M; Guétard D; Seidah NG; Bahraoui E
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):91-8. PubMed ID: 11062061
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.
Tochikura TS; Nakashima H; Kaneko Y; Kobayashi N; Yamamoto N
Jpn J Cancer Res; 1987 Jun; 78(6):583-9. PubMed ID: 3112074
[TBL] [Abstract][Full Text] [Related]
16. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
Zheng YT; Ben KL; Jin SW
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):239-43. PubMed ID: 10452099
[TBL] [Abstract][Full Text] [Related]
17. The ratio of defective HIV-1 particles to replication-competent infectious virions.
Bourinbaiar AS
Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666
[TBL] [Abstract][Full Text] [Related]
18. 7,8-secolignans from Schisandra wilsoniana and their anti-HIV-1 activities.
Zhang XJ; Yang GY; Wang RR; Pu JX; Sun HD; Xiao WL; Zheng YT
Chem Biodivers; 2010 Nov; 7(11):2692-701. PubMed ID: 21072768
[TBL] [Abstract][Full Text] [Related]
19. P53 in cytoplasm may enhance the accuracy of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
Bakhanashvili M; Novitsky E; Lilling G; Rahav G
Oncogene; 2004 Sep; 23(41):6890-9. PubMed ID: 15286711
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
